Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes

We measured the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time of medicinal and over-the-counter (OTC) tape preparations containing felbinac. When measuring the pH of each preparation, Felnabion (pH 4.5) was weakly acidic, and EMEC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug Discoveries & Therapeutics 2016, Vol.10(6), pp.300-306
Hauptverfasser: Wada, Yuko, Takaoka, Yukie, Nozawa, Mitsuru, Goto, Miho, Shimokawa, Ken-ichi, Ishii, Fumiyoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 306
container_issue 6
container_start_page 300
container_title Drug Discoveries & Therapeutics
container_volume 10
creator Wada, Yuko
Takaoka, Yukie
Nozawa, Mitsuru
Goto, Miho
Shimokawa, Ken-ichi
Ishii, Fumiyoshi
description We measured the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time of medicinal and over-the-counter (OTC) tape preparations containing felbinac. When measuring the pH of each preparation, Felnabion (pH 4.5) was weakly acidic, and EMEC and Tokuon (pH 7.0) were neutral. When measuring the water-vapor permeability of each preparation, that of a generic product, EMEC (380 g/m2/24h), was twice as high as that of a brand-name product, Seltouch (189 g/m2/24 h). The adhesive force was measured using the ball tack test. The adhesive forces of OTC drugs, Salomethyl, Homepass, and Tokuhon (1.04 g), were higher than that of Seltouch (0.06 g). Concerning peeling-force measurement, the peeling-forces of a generic product, Falzy (4.15 N), and an OTC drug, Omuneed (4.89 N), were higher than that of Seltouch (0.91 N). The elongation rates of a generic product, Sumilu (319%), and OTC drugs, Nabolin (298%) and Homepass (299%), were higher than that of Seltouch (251%), but that of Tokuhon (72%) was lower. The support flexibilities of EMEC (150 degrees) and Tokuhon (131 degrees) were higher than that of Seltouch (96 degrees). In addition, the peeling time of Seltouch was 120 min or more, whereas those of EMEC and Nabolin were 1.4 and 0.2 min, respectively. These results suggest that the differences in pharmaceutical properties, such as the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time, among the preparations markedly influence patients' subjective comfortableness. The results of this study facilitated individuals’ comfortableness-matched drug selection.
doi_str_mv 10.5582/ddt.2016.01053
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835369001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835369001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543t-24c79e3cfe9fff63a5b8258fdb11992f15283df3d84da481f19a1b1787c6c0013</originalsourceid><addsrcrecordid>eNpFkUFP3DAQhS1EBWjLtUfkYw9kG8dx4nCrlhaQkLjQqlJVWRNnvGuUOMH2HvYv9VfWu4GtD_Zo_L2n0TxCPrF8KYQsvnRdXBY5q5Y5ywU_IRdMSpbVsvx1eqw5OyeXIbzk6YhSMinOyHlR14UQdXlB_t6hQ281DdijjnZ0VHsbUwuoGT0NYDDuKLiOThAtukjbpDA20t8_H_7c0NU4TOCtW9O4QTptdsHqUW9wsBr6WbcBP4DGbTy0Jj9O6JNVoKOhrU9I5mDAa7qeR7k-qJ6eV9Rg31oHmkaYMHwkHwz0AS_f3gX58f3b8-o-e3y6e1h9fcy0KHnMilLXDXJtsDHGVBxEKwshTdcy1jSFYaKQvDO8k2UHaSGGNcBaVstaVzrPGV-Qz7NvmvR1iyGqwQaNfQ8Ox21QTHLBq2ZGlzOq_RiCR6MmbwfwO8VytY9IpYjUPiJ1iCgJrt68t-2A3RF_DyQBtzPwEiKs8QhA2pju8eCXvKv99d_3-K3TrhU6_g8hTqc9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835369001</pqid></control><display><type>article</type><title>Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Wada, Yuko ; Takaoka, Yukie ; Nozawa, Mitsuru ; Goto, Miho ; Shimokawa, Ken-ichi ; Ishii, Fumiyoshi</creator><creatorcontrib>Wada, Yuko ; Takaoka, Yukie ; Nozawa, Mitsuru ; Goto, Miho ; Shimokawa, Ken-ichi ; Ishii, Fumiyoshi</creatorcontrib><description>We measured the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time of medicinal and over-the-counter (OTC) tape preparations containing felbinac. When measuring the pH of each preparation, Felnabion (pH 4.5) was weakly acidic, and EMEC and Tokuon (pH 7.0) were neutral. When measuring the water-vapor permeability of each preparation, that of a generic product, EMEC (380 g/m2/24h), was twice as high as that of a brand-name product, Seltouch (189 g/m2/24 h). The adhesive force was measured using the ball tack test. The adhesive forces of OTC drugs, Salomethyl, Homepass, and Tokuhon (1.04 g), were higher than that of Seltouch (0.06 g). Concerning peeling-force measurement, the peeling-forces of a generic product, Falzy (4.15 N), and an OTC drug, Omuneed (4.89 N), were higher than that of Seltouch (0.91 N). The elongation rates of a generic product, Sumilu (319%), and OTC drugs, Nabolin (298%) and Homepass (299%), were higher than that of Seltouch (251%), but that of Tokuhon (72%) was lower. The support flexibilities of EMEC (150 degrees) and Tokuhon (131 degrees) were higher than that of Seltouch (96 degrees). In addition, the peeling time of Seltouch was 120 min or more, whereas those of EMEC and Nabolin were 1.4 and 0.2 min, respectively. These results suggest that the differences in pharmaceutical properties, such as the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time, among the preparations markedly influence patients' subjective comfortableness. The results of this study facilitated individuals’ comfortableness-matched drug selection.</description><identifier>ISSN: 1881-7831</identifier><identifier>EISSN: 1881-784X</identifier><identifier>DOI: 10.5582/ddt.2016.01053</identifier><identifier>PMID: 27725574</identifier><language>eng</language><publisher>Japan: International Research and Cooperation Association for Bio &amp; Socio-Sciences Advancement</publisher><subject>Brand-name products ; Drugs, Generic - analysis ; Drugs, Generic - chemistry ; felbinac ; generic products ; Humans ; Hydrogen-Ion Concentration ; Nonprescription Drugs - analysis ; Nonprescription Drugs - chemistry ; OTC ; Patient Selection ; Permeability ; Pharmaceutical Preparations - analysis ; Pharmaceutical Preparations - chemistry ; tape preparation ; Water</subject><ispartof>Drug Discoveries &amp; Therapeutics, 2016, Vol.10(6), pp.300-306</ispartof><rights>2016 International Research and Cooperation Association for Bio &amp; Socio-Sciences Advancement</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543t-24c79e3cfe9fff63a5b8258fdb11992f15283df3d84da481f19a1b1787c6c0013</citedby><cites>FETCH-LOGICAL-c543t-24c79e3cfe9fff63a5b8258fdb11992f15283df3d84da481f19a1b1787c6c0013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27725574$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wada, Yuko</creatorcontrib><creatorcontrib>Takaoka, Yukie</creatorcontrib><creatorcontrib>Nozawa, Mitsuru</creatorcontrib><creatorcontrib>Goto, Miho</creatorcontrib><creatorcontrib>Shimokawa, Ken-ichi</creatorcontrib><creatorcontrib>Ishii, Fumiyoshi</creatorcontrib><title>Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes</title><title>Drug Discoveries &amp; Therapeutics</title><addtitle>DD&amp;T</addtitle><description>We measured the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time of medicinal and over-the-counter (OTC) tape preparations containing felbinac. When measuring the pH of each preparation, Felnabion (pH 4.5) was weakly acidic, and EMEC and Tokuon (pH 7.0) were neutral. When measuring the water-vapor permeability of each preparation, that of a generic product, EMEC (380 g/m2/24h), was twice as high as that of a brand-name product, Seltouch (189 g/m2/24 h). The adhesive force was measured using the ball tack test. The adhesive forces of OTC drugs, Salomethyl, Homepass, and Tokuhon (1.04 g), were higher than that of Seltouch (0.06 g). Concerning peeling-force measurement, the peeling-forces of a generic product, Falzy (4.15 N), and an OTC drug, Omuneed (4.89 N), were higher than that of Seltouch (0.91 N). The elongation rates of a generic product, Sumilu (319%), and OTC drugs, Nabolin (298%) and Homepass (299%), were higher than that of Seltouch (251%), but that of Tokuhon (72%) was lower. The support flexibilities of EMEC (150 degrees) and Tokuhon (131 degrees) were higher than that of Seltouch (96 degrees). In addition, the peeling time of Seltouch was 120 min or more, whereas those of EMEC and Nabolin were 1.4 and 0.2 min, respectively. These results suggest that the differences in pharmaceutical properties, such as the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time, among the preparations markedly influence patients' subjective comfortableness. The results of this study facilitated individuals’ comfortableness-matched drug selection.</description><subject>Brand-name products</subject><subject>Drugs, Generic - analysis</subject><subject>Drugs, Generic - chemistry</subject><subject>felbinac</subject><subject>generic products</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Nonprescription Drugs - analysis</subject><subject>Nonprescription Drugs - chemistry</subject><subject>OTC</subject><subject>Patient Selection</subject><subject>Permeability</subject><subject>Pharmaceutical Preparations - analysis</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>tape preparation</subject><subject>Water</subject><issn>1881-7831</issn><issn>1881-784X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkUFP3DAQhS1EBWjLtUfkYw9kG8dx4nCrlhaQkLjQqlJVWRNnvGuUOMH2HvYv9VfWu4GtD_Zo_L2n0TxCPrF8KYQsvnRdXBY5q5Y5ywU_IRdMSpbVsvx1eqw5OyeXIbzk6YhSMinOyHlR14UQdXlB_t6hQ281DdijjnZ0VHsbUwuoGT0NYDDuKLiOThAtukjbpDA20t8_H_7c0NU4TOCtW9O4QTptdsHqUW9wsBr6WbcBP4DGbTy0Jj9O6JNVoKOhrU9I5mDAa7qeR7k-qJ6eV9Rg31oHmkaYMHwkHwz0AS_f3gX58f3b8-o-e3y6e1h9fcy0KHnMilLXDXJtsDHGVBxEKwshTdcy1jSFYaKQvDO8k2UHaSGGNcBaVstaVzrPGV-Qz7NvmvR1iyGqwQaNfQ8Ox21QTHLBq2ZGlzOq_RiCR6MmbwfwO8VytY9IpYjUPiJ1iCgJrt68t-2A3RF_DyQBtzPwEiKs8QhA2pju8eCXvKv99d_3-K3TrhU6_g8hTqc9</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Wada, Yuko</creator><creator>Takaoka, Yukie</creator><creator>Nozawa, Mitsuru</creator><creator>Goto, Miho</creator><creator>Shimokawa, Ken-ichi</creator><creator>Ishii, Fumiyoshi</creator><general>International Research and Cooperation Association for Bio &amp; Socio-Sciences Advancement</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2016</creationdate><title>Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes</title><author>Wada, Yuko ; Takaoka, Yukie ; Nozawa, Mitsuru ; Goto, Miho ; Shimokawa, Ken-ichi ; Ishii, Fumiyoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543t-24c79e3cfe9fff63a5b8258fdb11992f15283df3d84da481f19a1b1787c6c0013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Brand-name products</topic><topic>Drugs, Generic - analysis</topic><topic>Drugs, Generic - chemistry</topic><topic>felbinac</topic><topic>generic products</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Nonprescription Drugs - analysis</topic><topic>Nonprescription Drugs - chemistry</topic><topic>OTC</topic><topic>Patient Selection</topic><topic>Permeability</topic><topic>Pharmaceutical Preparations - analysis</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>tape preparation</topic><topic>Water</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wada, Yuko</creatorcontrib><creatorcontrib>Takaoka, Yukie</creatorcontrib><creatorcontrib>Nozawa, Mitsuru</creatorcontrib><creatorcontrib>Goto, Miho</creatorcontrib><creatorcontrib>Shimokawa, Ken-ichi</creatorcontrib><creatorcontrib>Ishii, Fumiyoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug Discoveries &amp; Therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wada, Yuko</au><au>Takaoka, Yukie</au><au>Nozawa, Mitsuru</au><au>Goto, Miho</au><au>Shimokawa, Ken-ichi</au><au>Ishii, Fumiyoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes</atitle><jtitle>Drug Discoveries &amp; Therapeutics</jtitle><addtitle>DD&amp;T</addtitle><date>2016</date><risdate>2016</risdate><volume>10</volume><issue>6</issue><spage>300</spage><epage>306</epage><pages>300-306</pages><issn>1881-7831</issn><eissn>1881-784X</eissn><abstract>We measured the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time of medicinal and over-the-counter (OTC) tape preparations containing felbinac. When measuring the pH of each preparation, Felnabion (pH 4.5) was weakly acidic, and EMEC and Tokuon (pH 7.0) were neutral. When measuring the water-vapor permeability of each preparation, that of a generic product, EMEC (380 g/m2/24h), was twice as high as that of a brand-name product, Seltouch (189 g/m2/24 h). The adhesive force was measured using the ball tack test. The adhesive forces of OTC drugs, Salomethyl, Homepass, and Tokuhon (1.04 g), were higher than that of Seltouch (0.06 g). Concerning peeling-force measurement, the peeling-forces of a generic product, Falzy (4.15 N), and an OTC drug, Omuneed (4.89 N), were higher than that of Seltouch (0.91 N). The elongation rates of a generic product, Sumilu (319%), and OTC drugs, Nabolin (298%) and Homepass (299%), were higher than that of Seltouch (251%), but that of Tokuhon (72%) was lower. The support flexibilities of EMEC (150 degrees) and Tokuhon (131 degrees) were higher than that of Seltouch (96 degrees). In addition, the peeling time of Seltouch was 120 min or more, whereas those of EMEC and Nabolin were 1.4 and 0.2 min, respectively. These results suggest that the differences in pharmaceutical properties, such as the pH, water-vapor permeability, adhesive force, peeling-force, elongation rate, support flexibility, and peeling time, among the preparations markedly influence patients' subjective comfortableness. The results of this study facilitated individuals’ comfortableness-matched drug selection.</abstract><cop>Japan</cop><pub>International Research and Cooperation Association for Bio &amp; Socio-Sciences Advancement</pub><pmid>27725574</pmid><doi>10.5582/ddt.2016.01053</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1881-7831
ispartof Drug Discoveries & Therapeutics, 2016, Vol.10(6), pp.300-306
issn 1881-7831
1881-784X
language eng
recordid cdi_proquest_miscellaneous_1835369001
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Brand-name products
Drugs, Generic - analysis
Drugs, Generic - chemistry
felbinac
generic products
Humans
Hydrogen-Ion Concentration
Nonprescription Drugs - analysis
Nonprescription Drugs - chemistry
OTC
Patient Selection
Permeability
Pharmaceutical Preparations - analysis
Pharmaceutical Preparations - chemistry
tape preparation
Water
title Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Generic%20selection%20criteria%20for%20safety%20and%20patient%20benefit%20%5BVI%5D:%20Comparing%20the%20physicochemical%20and%20pharmaceutical%20properties%20of%20brand-name,%20generic,%20and%20OTC%20felbinac%20tapes&rft.jtitle=Drug%20Discoveries%20&%20Therapeutics&rft.au=Wada,%20Yuko&rft.date=2016&rft.volume=10&rft.issue=6&rft.spage=300&rft.epage=306&rft.pages=300-306&rft.issn=1881-7831&rft.eissn=1881-784X&rft_id=info:doi/10.5582/ddt.2016.01053&rft_dat=%3Cproquest_cross%3E1835369001%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835369001&rft_id=info:pmid/27725574&rfr_iscdi=true